WHO clinical treatment guidelines for novel CoV based on MERS infection – first released, then updated on 28th January 2020.
Advanced stage illness includes pneumonia, ARDS & sepsis.
High-flow nasal oxygen (HFNO) or non-invasive ventilation (NIV) should only be used in selected patient.
According to WHO, based on SARS and MERS data, corticosteroids should not be routinely given systemically.
Yet, early into the pandemic US frontline doctors had great success using early corticosteroid treatment such as Budesonide, contrary to WHO’s blanket recommendation not to use it.
The Lancet study states “no antiviral treatment for coronavirus infection has been proven to be effective.” Yet, early on in pandemic doctors discover through past literature that Zinc + HCQ demonstrates to be an effective anti-viral.